Jon C Jones Selected Research

Jon C Jones Research Topics

8	Neoplasms (Cancer) 01/2020 - 01/2008
3	Multiple Myeloma 12/2019 - 02/2014
3	Neoplasm Metastasis (Metastasis) 03/2014 - 02/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2015
1	Residual Neoplasm 03/2015
1	Lymphoma (Lymphomas) 03/2015
1	Osteolysis 03/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2014
1	Plasmacytoma 02/2014
1	Bone Resorption 02/2014
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2009
1	Prostatic Neoplasms (Prostate Cancer) 01/2008

2	Chimeric Antigen ReceptorsIBA 01/2020 - 12/2019
2	Astatine-211IBA 10/2019 - 03/2015
2	Radioisotopes (Radionuclides)IBA 07/2015 - 03/2015
2	RANK LigandIBA 03/2014 - 02/2014
1	acalabrutinibIBA 01/2020
1	ibrutinibIBA 01/2020
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2019
1	B-Cell Maturation AntigenIBA 12/2019
1	Lenalidomide (CC 5013)FDA Link 12/2019
1	Monoclonal AntibodiesIBA 03/2015
1	CalciumIBA 03/2014
1	Docetaxel (Taxotere)FDA Link 03/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2014
1	OsteoprotegerinIBA 03/2014
1	StreptavidinIBA 02/2014
1	ADP-ribosyl Cyclase 1IBA 02/2014
1	procaine isothiocyanate (PRIT)IBA 02/2014
1	Biotin (Vitamin H)FDA Link 02/2014
1	Matrix Metalloproteinases (MMPs)IBA 02/2014
1	Zoledronic Acid (Zometa)FDA Link 02/2014
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2009
1	Enoxaparin (Lovenox)FDA LinkGeneric 02/2009
1	LigandsIBA 01/2008
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 01/2008
1	Messenger RNA (mRNA)IBA 01/2008
1	Proteins (Proteins, Gene)FDA Link 01/2008